imple goiter (SG), that is an enlarged nontoxic thyroidgland which is not the result of an inflammatory or neo-plastic process, although on the wane, remains a nearly globalproblem (1,2). Until increasingly employed iodization pro-grams significantly reduces its prevalence, the etiology as wellasthetherapyofbenignnontoxicgoitershouldremaininfocus.It is well accepted that sporadic or endemic SG (2,3), alongwith the other common thyroid diseases co-existing withgoiterincludingGraves’disease(4),toxicmultinodulargoiter,and Hashimoto’s thyroiditis (5), is a complex disease. Theseareallcommonandmultifactorialwiththeclinicalphenotyperepresenting the net effect of many contributing genetic andenvironmental factors. It has been difficult to disentangle en-vironmental influences from genetic susceptibility, progresshasbeenslowinrevealingcandidategenes,andlittleisknownof the roles of gene–environment and gene–gene interaction.AroleforgeneticfactorsintheetiologyofSGhaslongbeenrecognized. Familial aggregation is illustrated by the 5–10times greater prevalence of SG among the probands of firstdegree female relatives as compared with the backgroundpopulation (2,3). Subsequently, twin studies (3), demonstrat-ing a significantly higher concordance rate in monozygotic(53%,95%CI23–83%)thanindizygotictwins(18%,95%CI5–35%), have clarified that the familial aggregation is the resultof shared genes and not of shared environment. Our study ina nonendemic goiter area (3) estimated that heritability oradditivegeneticfactorsaccountedfor82%(95%CI,67–92%)ofcases, while specific individual environmental factors likelyaccounted for 18% (95% CI, 8–33%) of goiter development infemales. The influence of heritability decreases with the pres-ence of major environmental factors such as iodine deficiency(2). As a consequence, susceptibility genes are more easilydiscerned in nonendemic goiter areas. The pronounced influ-ence of heritability on thyroid size (6) and thyroid nodularity(7), with or without concomitant clinical goiter, strengthenstheconceptthatthereisaconsiderablegeneticinfluenceonthedevelopment of SG.A detailed account of the genetic influences on the devel-opment of SG is beyond the scope of this editorial. Mutationsand polymorphisms in the genes for thyroid peroxidase(TPO), thyroglobulin (Tg), sodium iodide symporter (NIS),and thyrotropin receptor (TSHR), however, all have a role (8–10). SG is polygenic, moreover, with no single gene beingeither necessary or sufficient for disease development. Thelimited studies to date suggest that the genetic backgroundvariesfromfamilytofamily.Furthermore,ourunderstandingof the interaction between heredity and environment is verylimited. There is a clear lack of longitudinal studies in indi-viduals with genetically based susceptibility to determinehow and when environmental triggers such as iodine defi-ciency or cigarette smoking influence the occurrence of SG.When studying this issue it is important to realize that SG isnot one single phenotype.The pronounced sex difference in prevalence of thyroiddisease, often 5–10 times more common in females, is puz-zling. Theoretically, a skewed X chromosome inactivation(XCI) pattern—which is probably genetically determined—andresultanttissuechimerismcouldofferanovelexplanationfor the female preponderance of thyroid disorders, includingthat of SG (11). The X chromosome harbors genetic markerslinked to SG (12) and a skewed XCI (i.e., predominant inac-tivation of the normal X chromosome) could result in ex-pression of X-linked diseases. When recently tested, thishypothesis was rejected (13). Intake of oral contraceptives,another potential explanation for the sex-related difference inprevalence of SG, is actually associated with a decreasedthyroid size (14).Whereas environmental influences can be modified whilegenetic background cannot, much of the current focus on theetiology and treatment of SG has been on identifying andcorrectingenvironmentalinfluences.Large-scalestudieshavedemonstrated the importanceof surprisingly small variationsiniodine intake notonly for the prevalence ofovert goiter butalso for the regulation of thyroid size in nongoitrous indi-viduals(15).Interestingly,arelativelysmallincreaseiniodineintake, for just a few years, leads to a measurable and signif-icant decrease in thyroid volume (15), suggesting that modi-fyingiodineintakemayrapidlyleadtoadecreaseinincidenceof SG and subsequently in overt nodular toxic goiter. Studiesof this kind, such as performed in Denmark (16), will un-doubtedly provide further evidence of the interaction be-tween genetic susceptibility and environmental triggers.Another modifiable goitrogen is cigarette smoking. Thereis abundant evidence of its importance, from both case–control studies and studies in discordant twin pairs (17,18).Large-scale studies have demonstrated an interaction be-tween low iodine intake and thiocyanate generating cigarettesmoking, offering an explanation for the effect and providinga means to eliminate one or more factors in the genesis ofgoiter (19).
Read full abstract